AMARIN CORP PLC\UK Gain (Loss) on Derivative Instruments, Net, Pretax
AMARIN CORP PLC\UK (AMRN) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $0 for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2015-05-08
- AMARIN CORP PLC\UK gain (loss) on derivative instruments, net, pretax for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- AMARIN CORP PLC\UK gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-12-31 was -$200.00K.
- AMARIN CORP PLC\UK gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-09-30 was $1.50M, a 7.14% increase year-over-year.
- AMARIN CORP PLC\UK gain (loss) on derivative instruments, net, pretax for the quarter ending 2014-06-30 was $1.50M, a 78.57% decline year-over-year.
- AMARIN CORP PLC\UK gain (loss) on derivative instruments, net, pretax for fiscal 2014 was $6.30M, a 80.00% increase from fiscal 2013.
- AMARIN CORP PLC\UK gain (loss) on derivative instruments, net, pretax for fiscal 2013 was $3.50M.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | -$200.00K derived: sum of 2 quarters · filed 2015-05-08 | $1.30M derived: sum of 3 quarters · filed 2015-05-08 | $2.80M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | -$200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $1.30M derived: sum of 2 quarters · filed 2015-03-03 | $2.80M derived: sum of 3 quarters · filed 2015-03-03 | $6.30M 10-K · filed 2015-03-03 |
| 2014-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.00M derived: sum of 2 quarters · filed 2014-11-06 | $6.50M 10-Q · filed 2014-11-06 | $2.60M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-06-30 | $1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $5.00M 10-Q · filed 2014-08-07 | $1.10M derived: sum of 3 quarters · filed 2015-05-08 | $2.50M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-03-31 | $3.50M 10-Q · filed 2015-05-08 | -$400.00K derived: sum of 2 quarters · filed 2015-05-08 | $1.00M derived: sum of 3 quarters · filed 2015-05-08 | $8.00M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | -$3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$2.50M derived: sum of 2 quarters · filed 2015-03-03 | $4.50M derived: sum of 3 quarters · filed 2015-03-03 | $3.50M 10-K · filed 2015-03-03 |
| 2013-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $8.40M derived: sum of 2 quarters · filed 2014-11-06 | $7.40M 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $6.00M 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$1.00M 10-Q · filed 2014-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |